How Imipenem can Save You Time, Stress, and Money.
MI-CP151 was a phase 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre research To judge numerous intravenous doses of sifalimumab, in Grownup people with dermatomyositis or polymyositis (NCT00533091). Principal demo goals had been To judge the security and tolerability of sifalimumab in dermatomyositis or polymyositis s